A critical advance in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital tumor inhibitor protein is frequently lost in various types of cancer, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research